RxDoctor Payments Data

Joel Stewart, MD

Plastic Surgery Within the Head and Neck · Carrollton, GANPI 1447293584

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $2,414 of the $4,016 with a category attached, or 60.1%. AbbVie accounts for 67.4% of it on its own, with 18 other manufacturers making up the rest. Reporting peaked in 2021 at $2,206 and has fallen 91.3% since, to $192 in 2025.

$4,016in general payments, 2019–2025

Across 99 payments — averaging $40.56 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$3K
  • Mentor Worldwide LLC$263
  • Medtronic$214
  • Comsort, Inc$150
  • Integra Lifesciences Corporation$119
  • Boston Scientific$106
  • plus $456 from 13 others

What the payments were for

  • Consulting fees$3158%
  • Travel & lodging$1,28732%
  • Food & beverage$2,41460%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,016 in reported general payments places this provider in the 60th percentile of 24 plastic surgery within the head and neck providers in Georgia.

See all plastic surgery within the head and neck providers in Georgia

Medicare billing

Part B allowed, 2024
$22,433
Medicare patients
28
Services billed
79

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Mupirocin31$208
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen27$199
Ondansetron OdtOndansetron16$132
Cephalexin34$116
Chlorhexidine Gluconate31$113
Doxycycline Hyclate15$84
Ondansetron Hcl19$68
Methocarbamol14$56

Paid to pharmacies, not to this prescriber.

Other plastic surgery within the head and neck in Carrollton

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →